Luba Shapiro is an experienced Clinical Operations and Research Specialist with 17 years in the field, focused on cardiology, oncology, and neurology. Luba has been involved in numerous studies, ranging from Phase 1 to Phase 4, and has specific expertise in elderly patient populations.
Prior to joining BioGenCell, Luba founded Scopus LTD, managing all aspects of global clinical trials from medical writing, through site selection to regulatory compliance. Before that, she served as the Director of Clinical Operations at Galmed Pharmaceuticals, overseeing global clinical trials, CRAs/CROs and vendor management. Luba has held leading roles as Clinical Project Manager and Senior Clinical Research Associate, responsible for site feasibility, start-up phase, study initiation, monitoring, and data management in multi-regional studies.
Her background includes positions at Quintiles (today: IQVIA) and Q-Trials, where she gained substantial experience in study start-up and site monitoring. She is known for her proficiency in GCP compliance, vendor management, and multi-center study coordination in pharmaceutical and device trials.